Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Added

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare non-destructive, read-only, idempotent behavior. The description adds details like data sources (SEC EDGAR/XBRL, FAERS), handling of off-calendar fiscal years, sorting by primary metric, and citation URIs. No contradictions.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is front-loaded with example queries and well-structured, but slightly verbose. Every sentence adds value, though a few words could be trimmed without loss.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple metrics, citations), the description fully explains what it returns and how it works. No output schema exists, but the description adequately covers return format and behavior.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema covers 100% of parameters with clear descriptions. The description adds practical context: explains the format of values (tickers for company, drug names), item constraints (2-5), and that output is paired data with citations and sorted.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool compares 2-5 entities (companies or drugs) in one parallel call, pulling specific financial metrics for companies and adverse-event/FDA/trial data for drugs. It is distinct from sibling tools like entity_profile which handles single entities.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly advises to prefer this over sequential lookups when comparing entities, provides example natural language queries, and specifies the entity count range and types. It effectively communicates when and why to use this tool.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Multiple tool families have unclear boundaries: ask_pipeworx and ask_pipeworx_beta are explicitly identical right now, suggest_questions and discover_tools are near-duplicates, and ai_visibility_check is a subset of scan_competitor_ai_presence. The five polymarket_* tools are heavily overlapping in purpose and rely on long descriptions to distinguish them, which an agent must read carefully to avoid misselection.

Naming Consistency3/5

All names are lowercase snake_case and there are helpful prefixes (polymarket_*, ask_pipeworx_*, pipeworx_*), but the verb/noun ordering is inconsistent: verb-first names (generate_llms_txt, resolve_entity, scan_dependency) sit alongside noun-first names (bet_research, entity_profile, recent_changes) and bare verbs (forget, recall, remember). Sub-families are internally consistent, but the set as a whole follows no single convention.

Tool Count2/5

32 tools is over the 'too many' threshold, and the scope is a grab-bag rather than a focused server: data research, prediction-market analysis, npm dependency checks, llms.txt generation, memory utilities, subscriptions, and exactly one tarot tool. The server is named 'Tarot Draw' yet 31 of 32 tools serve a completely different purpose, making the count wildly mismatched to the apparent identity.

Completeness2/5

For the inferred Pipeworx data/prediction-market domain the coverage is genuinely deep — ask/grounded/deep research, entity resolution, profiles, comparisons, validation, subscriptions, alerts, edge tracking, and arbitrage all exist. But for the stated purpose ('Tarot Draw'), the surface is one draw tool with no deck details, spreads, reading history, or reversal support, and the data tools' domain is so diffuse that an agent cannot rely on the set forming a coherent workflow.